Outsourced Pharma Capabilities Update August 2026: Nanoparticles

Nanoparticle programs can stall when early formulation choices fail to hold up through scale-up, tech transfer, and manufacturing.

Join leading CDMO experts on August 18 at 11:00 AM ET to learn how decisions around lipid or polymer selection, particle engineering, process design, and manufacturability can impact downstream success.

Register now to gain practical insights that will help you evaluate CDMO approaches, ask sharper formulation questions, and reduce risk before nanoparticle challenges become costly development setbacks.